Skip to Content
Merck
CN

181978

Poly(ethyleneimine) solution

average Mn ~60,000 by GPC, average Mw ~750,000 by LS, 50 wt. % in H2O

Synonym(s):

Ethyleneimine polymer solution, PEI

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

CAS Number:
MDL number:
UNSPSC Code:
12162002
PubChem Substance ID:
NACRES:
NA.23
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


vapor pressure

9 mmHg ( 20 °C)

Quality Level

mol wt

average Mn ~60,000 by GPC, average Mw ~750,000 by LS

concentration

50 wt. % in H2O

SMILES string

N1CC1

InChI

1S/C2H5N/c1-2-3-1/h3H,1-2H2

InChI key

NOWKCMXCCJGMRR-UHFFFAOYSA-N

Application

Detergents, adhesives, water treatment, printing inks, dyes, cosmetics, and paper industry, adhesion promoter, lamination primer, fixative agent, flocculant, cationic dispersant, stability enhancer, surface activator, chelating agent, scavenger for aldehydes and oxides.
Protein precipitant.

Physical form

Branched polymer


Still not finding the right product?

Explore all of our products under Poly(ethyleneimine) solution


pictograms

Exclamation markEnvironment

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

Storage Class

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Articles

Gene therapy has become one of the most discussed techniques in biomedical research in recent years.

Microfluidic assembly improves polyamine nanoencapsulation of nucleic acids, overcoming challenges like polydispersity and poor reproducibility.

Professor Yoshiki Katayama (Kyushu University, Japan) discusses recent advances in drug delivery systems and strategies that exploit the EPR effect, with a special focus on stimuli-responsive systems based on novel materials.

View All Articles

Andrew Jajack et al.
PloS one, 14(1), e0210286-e0210286 (2019-01-17)
Insurmountable detection challenges will impede the development of many of the next-generation of lab-on-a-chip devices (e.g., point-of-care and real-time health monitors). Here we present the first membrane-based, microfluidic sample preconcentration method that is continuous, quantifiable, simple, and capable of working
Xinyue Yuan et al.
Nature communications, 11(1), 4854-4854 (2020-09-27)
Chronic imaging of neuronal networks in vitro has provided fundamental insights into mechanisms underlying neuronal function. Current labeling and optical imaging methods, however, cannot be used for continuous and long-term recordings of the dynamics and evolution of neuronal networks, as
Laura R H Ip et al.
Oncotarget, 6(12), 10548-10562 (2015-04-15)
Treatment options for ovarian cancer patients remain limited and overall survival is less than 50% despite recent clinical advances. The lipid phosphatase inositol polyphosphate 4-phosphatase type II (INPP4B) has been described as a tumor suppressor in the PI3K/Akt pathway with



Global Trade Item Number

SKUGTIN
181978-5G04061838755483
181978-100G04061838755469
181978-18KG04061838755476
181978-250G04061838252203